- Home
- OPI vs LVTX Comparison
OPI vs LVTX Comparison
Compare OPI & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPI
- LVTX
- Stock Information
- Founded
- OPI 2009
- LVTX 2016
- Country
- OPI United States
- LVTX Netherlands
- Employees
- OPI N/A
- LVTX N/A
- Industry
- OPI Real Estate Investment Trusts
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- OPI Real Estate
- LVTX Health Care
- Exchange
- OPI Nasdaq
- LVTX Nasdaq
- Market Cap
- OPI 40.8M
- LVTX 41.3M
- IPO Year
- OPI 2009
- LVTX 2021
- Fundamental
- Price
- OPI $0.45
- LVTX $1.47
- Analyst Decision
- OPI
- LVTX Hold
- Analyst Count
- OPI 0
- LVTX 4
- Target Price
- OPI N/A
- LVTX $1.58
- AVG Volume (30 Days)
- OPI 32.1M
- LVTX 162.8K
- Earning Date
- OPI 10-29-2025
- LVTX 08-13-2025
- Dividend Yield
- OPI 6.87%
- LVTX N/A
- EPS Growth
- OPI N/A
- LVTX N/A
- EPS
- OPI N/A
- LVTX N/A
- Revenue
- OPI $466,972,000.00
- LVTX $4,990,000.00
- Revenue This Year
- OPI N/A
- LVTX N/A
- Revenue Next Year
- OPI N/A
- LVTX N/A
- P/E Ratio
- OPI N/A
- LVTX N/A
- Revenue Growth
- OPI N/A
- LVTX N/A
- 52 Week Low
- OPI $0.18
- LVTX $0.85
- 52 Week High
- OPI $2.44
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- OPI 54.58
- LVTX 38.60
- Support Level
- OPI $0.22
- LVTX $1.53
- Resistance Level
- OPI $1.13
- LVTX $1.57
- Average True Range (ATR)
- OPI 0.13
- LVTX 0.04
- MACD
- OPI 0.04
- LVTX -0.01
- Stochastic Oscillator
- OPI 27.28
- LVTX 25.16
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.